Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-masked, Multicenter, Placebo Controlled Study of Keluo Xin Capsule on Efficacy and Safety in Patients With Diabetic Retinopathy

NCT03258242 is registered in ClinicalTrials.gov with Chengdu Kanghong Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT03258242
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03258242 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-masked, Multicenter, Placebo Controlled Study of Keluo Xin Capsule on Efficacy and Safety in Patients With Diabetic Retinopathy
Lead sponsor
Chengdu Kanghong Pharmaceutical Co., Ltd.
Phase
Phase 2
Overall status
Unknown status
Start date
August 31, 2017
Completion date
February 28, 2020
Enrollment
198 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

moderately severe to severe npdr